Implantable cardioverter-defibrillator (ICD) therapy is clearly an effective therapy for selected
patients in definable populations. The benefits and risks of ICD therapy are directly impacted …

Aims To assess the impact of MultiPoint™ Pacing (MPP) in cardiac resynchronization
therapy (CRT) non-responders after 6 months of standard biventricular pacing (BiVP) …

Guideline-directed medical therapy, such as angiotensin-converting enzyme inhibitors, beta
blockers, and spironolactone have improved symptoms and survival in patients with …

Background Atrial fibrillation (AF) is correlated with a poor biventricular pacing and
inadequate response to cardiac resynchronization therapy (CRT). Biventricular pacing …

Heart failure, be it with preserved or reduced left ventricular function, is the cardiovascular
epidemic of the 21st century, 1–4 and it thus appropriate to devote a whole issue of the …

Abstract Aims The HeartLogic algorithm combines multiple implantable defibrillator (ICD)
sensor data and has proved to be a sensitive and timely predictor of impending heart failure …

Aims A novel therapy offering cardiac resynchronization therapy (CRT) with an additional
lead placed in His bundle has been reported in a few case reports and case series as …

Abstract Aims The HeartLogic Index combines data from multiple implantable cardioverter
defibrillators (ICDs) sensors and has been shown to accurately stratify patients at risk of …

Background The optimal timing for cardiac resynchronization therapy (CRT) after diagnosis
of new‐onset left bundle branch block (LBBB)‐associated idiopathic nonischemic …

Abstract Aims In the IN-TIME trial, automatic daily implant-based multiparameter
telemonitoring significantly improved clinical outcomes in patients with chronic systolic heart …